Promotes the Proliferation, Migration, Invasiveness, and Epithelial-mesenchymal Transition of Lung Cancer Cells by Regulating
Overview
Cell Biology
Authors
Affiliations
Long noncoding RNA small nucleolar RNA host gene 4 () is usually up-regulated in cancer and regulates the malignant behavior of cancer cells. However, its role in lung cancer remains elusive. In this study, we silenced the expression of in NCI-H1437 and SK-MES-1, two representative non-small-cell lung cancer cell lines, by transfecting them with siRNA (small interfering RNA) that specifically targets . We observed significantly inhibited cell proliferation in vitro and reduced tumor growth in vivo after silencing. knockdown also led to cell cycle arrest at the G1 phase, accompanied with down-regulation of cyclin-dependent kinases CDK4 and CDK6. The migration and invasiveness of these two cell lines were remarkably inhibited after silencing. Moreover, our study revealed that the epithelial-mesenchymal transition (EMT) of lung cancer cells was suppressed by silencing, as evidenced by up-regulated E-cadherin and down-regulated SALL4, Twist, and vimentin. In addition, we found that silencing induced up-regulation of . inhibition abrogated the effect of silencing on proliferation and invasion of lung cancer cells. In conclusion, our findings demonstrate that is required by lung cancer cells to maintain malignant phenotype. probably exerts its pro-survival and pro-metastatic effects by sponging anti-tumor .
lncRNA SNHG4 enhanced gastric cancer progression by modulating miR-409-3p/CREB1 axis.
Cheng Z, Hua Y, Cao Y, Qin J Oncol Res. 2024; 33(1):185-198.
PMID: 39735673 PMC: 11671409. DOI: 10.32604/or.2024.042281.
Current understanding of functional peptides encoded by lncRNA in cancer.
Tian H, Tang L, Yang Z, Xiang Y, Min Q, Yin M Cancer Cell Int. 2024; 24(1):252.
PMID: 39030557 PMC: 11265036. DOI: 10.1186/s12935-024-03446-7.
MicroRNA-98: the multifaceted regulator in human cancer progression and therapy.
Hazari V, Samali S, Izadpanahi P, Mollaei H, Sadri F, Rezaei Z Cancer Cell Int. 2024; 24(1):209.
PMID: 38872210 PMC: 11177407. DOI: 10.1186/s12935-024-03386-2.
Ren H, Zheng J, Zhu Y, Wang L, Liu J, Xu H Medicine (Baltimore). 2023; 102(50):e36611.
PMID: 38115286 PMC: 10727658. DOI: 10.1097/MD.0000000000036611.
Song B, Chen Y BMC Pulm Med. 2023; 23(1):513.
PMID: 38114929 PMC: 10731904. DOI: 10.1186/s12890-023-02818-5.